The DOI matches its Crossref record; 323 of the 323 references it cites were found in a registry or an index.
Psychosis pathways converge via D2High dopamine receptors
Abstract
The objective of this review is to identify a target or biomarker of altered neurochemical sensitivity that is common to the many animal models of human psychoses associated with street drugs, brain injury, steroid use, birth injury, and gene alterations. Psychosis in humans can be caused by amphetamine, phencyclidine, steroids, ethanol, and brain lesions such as hippocampal, cortical, and entorhinal lesions. Strikingly, all of these drugs and lesions in rats lead to dopamine supersensitivity and increase the high-affinity states of dopamine D2 receptors, or D2High, by 200-400% in striata. Similar supersensitivity and D2High elevations occur in rats born by Caesarian section and in rats treated with corticosterone or antipsychotics such as reserpine, risperidone, haloperidol, olanzapine, quetiapine, and clozapine, with the latter two inducing elevated D2High states less than that caused by haloperidol or olanzapine. Mice born with gene knockouts of some possible schizophrenia susceptibility genes are dopamine supersensitive, and their striata reveal markedly elevated D2High states; suchgenes include dopamine-beta-hydroxylase, dopamine D4 receptors, G protein receptor kinase 6, tyrosine hydroxylase, catechol-O-methyltransferase, the trace amine-1 receptor, regulator of G protein signaling RGS9, and the RIIbeta form of cAMP-dependent protein kinase (PKA). Striata from mice that are not dopamine supersensitive did not reveal elevated D2High states; these include mice with knockouts of adenosine A2A receptors, glycogen synthase kinase GSK3beta, metabotropic glutamate receptor 5, dopamine D1 or D3 receptors, histamine H1, H2, or H3 receptors, and rats treated with ketanserin or aD1 antagonist. The evidence suggests that there are multiple pathways that convergetoelevate the D2High state in brain regions and that this elevation may elicit psychosis. This proposition is supported by the dopamine supersensitivity that is a common feature of schizophrenia and that also occurs in many types of genetically altered, drug-altered, and lesion-altered animals. Dopamine supersensitivity, in turn, correlates with D2High states. The finding that all antipsychotics, traditional and recent ones, act on D2High dopamine receptors further supports the proposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–323 of 323
Yui, K., Goto, K., Ikemoto, S., Ishiguro, T., Angrist, B., Duncan, G. E., Sheitman, B., Lieberman, J. A., Bracha, S., & Ali, S. F. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000575 · Cited by 95
Morris, D. W., McGhee, K. A., Schwaiger, S., Scully, P. J., Quinn, J., Meagher, D. J., Waddington, J. L., Gill, M., & Corvin, A. P. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00527-3 · Cited by 94
Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density
LaHoste, G. J., & Marshall, J. F. (1992) · Synapse · doi:10.1002/syn.890120103 · Cited by 93
REGULATORs OF G PROTEIN SIGNALING & DRUGS OF ABUSE
Traynor, J. R. (2005) · Molecular Interventions · doi:10.1124/mi.5.1.7 · Cited by 93
Cardiac Muscarinic Receptors. Cooperativity as the Basis for Multiple States of Affinity
Chidiac, P., Green, M. A., Pawagi, A. B., & Wells, J. W. (1997) · Biochemistry · doi:10.1021/bi961939t · Cited by 92
Sequence of Interactions in Receptor-G Protein Coupling
Herrmann, R., Heck, M., Henklein, P., Henklein, P., Kleuss, C., Hofmann, K. P., & Ernst, O. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311166200 · Cited by 90
Wynn, J. K., Dawson, M. E., Schell, A. M., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.018 · Cited by 87
Kubota, Y., Ito, C., Sakurai, E., Sakurai, E., Watanabe, T., & Ohtsu, H. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01189.x · Cited by 86
Meincke, U., Mörth, D., Voß, T., Thelen, B., Geyer, M. A., & Gouzoulis‐Mayfrank, E. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0523-0 · Cited by 84
Karasinska, J. M., George, S. R., Cheng, R., & O’Dowd, B. F. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04353.x · Cited by 83
Lawford, B. R., Young, R. M., Swagell, C. D., Barnes, M., Burton, S. C., Ward, W. K., Heslop, K., Shadforth, S., van Daal, A., & Morris, C. P. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.08.020 · Cited by 83
RGS mRNA Expression in Rat Striatum
Burchett, S. A., Bannon, M. J., & Granneman, J. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721529.x · Cited by 82
Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia
Jönsson, E. G., Nöthen, M. M., Neidt, H., Forslund, K., Rylander, G., Mattila‐Evenden, M., Åsberg, M., Propping, P., & Sedvall, G. C. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00033-x · Cited by 82
Richtand, N. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301163 · Cited by 82
Alterations in the dopaminergic receptor system after chronic administration of cocaine
Alburges, M. E., Narang, N., & Wamsley, J. K. (1993) · Synapse · doi:10.1002/syn.890140409 · Cited by 82
No Major Schizophrenia Locus Detected on Chromosome 1q in a Large Multicenter Sample
Levinson, D. F., Holmans, P., Laurent‐Levinson, C., Riley, B. P., Pulver, A. E., Gejman, P. V., Schwab, S. G., Williams, N. M., Owen, M. J., Wildenauer, D. B., et al. (2002) · Science · doi:10.1126/science.1069914 · Cited by 82
Knockout Mice Reveal Opposite Roles for Serotonin 1A and 1B Receptors in Prepulse Inhibition
Dulawa, S. C. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00164-5 · Cited by 80
Lipska, B. K., Lerman, D. N., Khaing, Z. Z., & Weinberger, D. R. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03047.x · Cited by 79
Bai, J., He, F., Novikova, S. I., Undie, A. S., Dracheva, S. M., Haroutunian, V. H., & Lidow, M. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.022 · Cited by 79
Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats
Bast, T., Zhang, W., Feldon, J., & White, I. M. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00409-3 · Cited by 78
Linkage of eye movement dysfunction to chromosome 6p in schizophrenia: Additional evidence
Matthysse, S., Holzman, P. S., Gusella, J. F., Levy, D. L., Harte, C. B., Jørgensen, Å., Møller, L., & Parnas, J. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30030 · Cited by 78
Seeman, P. M., Tallerico, T., Ko, F., Tenn, C. C., & Kapur, S. (2002) · Synapse · doi:10.1002/syn.10139 · Cited by 77
Self-citationCrawford, C. A., Drago, J., Watson, J. B., & Levine, M. (1997) · Neuroreport · doi:10.1097/00001756-199707280-00021 · Cited by 77
Antipsychotic drugs, dopamine receptors, and schizophrenia
Seeman, P. M. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(00)00007-4 · Cited by 77
Self-citationAntiparkinson concentrations of pramipexole and PHNO occupy dopamine D2high and D3high receptors
Seeman, P. M., Ko, F., Willeit, M., McCormick, P. N., & Ginovart, N. (2005) · Synapse · doi:10.1002/syn.20193 · Cited by 77
Self-citationRobinson, S., Smith, D. M., Mizumori, S. J. Y., & Palmiter, R. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405084101 · Cited by 76
Preferential Interaction between the Dopamine D2 Receptor and Arrestin2 in Neostriatal Neurons
Macey, T. A., Gurevich, V. V., & Neve, K. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001495 · Cited by 75
Hippocampal deformities in the unaffected siblings of schizophrenia subjects
Tepest, R., Wang, L., Miller, M. I., Falkai, P., & Csernansky, J. G. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00702-9 · Cited by 74
Schröeder, H., Grecksch, G., Becker, A., Bogerts, B., & Hoellt, V. (1999) · Psychopharmacology · doi:10.1007/s002130051032 · Cited by 73
Structure, alternative splicing, and expression of the human RGS9 gene
Zhang, K., Howes, K. A., He, W., Bronson, J. D., Pettenati, M. J., Chen, C.-K., Palczewski, K., Wensel, T. G., & Baehr, W. (1999) · Gene · doi:10.1016/s0378-1119(99)00393-5 · Cited by 73
COMT haplotypes suggest P2 promoter region relevance for schizophrenia
Palmatier, M. A., PAKSTIS, A. J., Speed, W. C., Paschou, P., Goldman, D. A., Odunsi, A., Okonofua, F. E., Kajuna, S. L. B., Karoma, N. J., Kungulilo, S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001496 · Cited by 73
Dopamine receptor functions: lessions from knockout mice
Glickstein, S. B., & Schmauss, C. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00145-0 · Cited by 72
Female schizophrenia patients have prepulse inhibition deficits
BRAFF, D. L., Light, G. A., Ellwanger, J., Sprock, J., & Swerdlow, N. R. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.030 · Cited by 72
Methamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia
Akiyama, K., Kanzaki, A., Tsuchida, K., & Ujike, H. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90035-3 · Cited by 70
Feifel, D., Melendez, G., & Shilling, P. D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300378 · Cited by 70
Birth insult increases amphetamine-induced behavioral responses in the adult rat
El‐Khodor, B. F., & Boksa, P. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00194-8 · Cited by 69
Self-citationAnesthetics inhibit high‐affinity states of dopamine D2 and other G‐linked receptors
Seeman, P. M., & Kapur, S. (2003) · Synapse · doi:10.1002/syn.10221 · Cited by 69
Self-citationBehavioral changes in rats with early ventral hippocampal damage vary with age at damage
Wood, G. K., Lipska, B. K., & Weinberger, D. R. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(97)00050-3 · Cited by 69
Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice
Brody, S. A., Conquet, F., & Geyer, M. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1635-3 · Cited by 68
Carey, J. C., & Viskochil, D. H. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1<7::aid-ajmg4>3.0.co;2-# · Cited by 68
Chen, J., Moratalla, R., Yu, L., Martín, A. B., Xu, K., Bastia, E., Hackett, E., Alberti, I., & Schwarzschild, M. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300152 · Cited by 68
Self-citationBeraki, S., Aronsson, F., Karlsson, H., Ögren, S. O., & Kristensson, K. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001545 · Cited by 67
Taymans, J., Kia, H. K., Claes, R., Cruz, C., Leysen, J. E., & Langlois, X. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03336.x · Cited by 67
Linkage and association studies of schizophrenia
McGuffin, P., Tandon, K., & Corsico, A. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0028-y · Cited by 67
Seeger, T., Thal, L. J., & Gardner, E. L. (1982) · Psychopharmacology · doi:10.1007/bf00435275 · Cited by 67
Meng, Z., Feldpausch, D. L., & Merchant, K. M. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00196-x · Cited by 66
A genomewide linkage study of age at onset in schizophrenia*
Cardno, A. G., Holmans, P., Rees, M. I., Jones, L. A., McCarthy, G. M., Hamshere, M. L., Williams, N. M., Norton, N., Williams, H. J., Fenton, I., et al. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1404 · Cited by 66
Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta‐analysis
Jönsson, E. G., Sillén, A., Vares, M., Ekholm, B., Terenius, L. Y., & Sedvall, G. C. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20004 · Cited by 66
Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia
Duncan, E., Szilagyi, S., Efferen, T. R., Schwartz, M. P., Parwani, A., Chakravorty, S., Madonick, S. H., Kunzova, A., Harmon, J. W., Angrist, B., et al. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1372-z · Cited by 65
Greenberg, B. D., & Segal, D. S. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90137-6 · Cited by 64
Pierre, P. J., & Vezina, P. (1998) · Psychopharmacology · doi:10.1007/s002130050658 · Cited by 64
Prepulse Inhibition Deficits in GAD65 Knockout Mice and the Effect of Antipsychotic Treatment
Heldt, S. A., Green, A. M., & Ressler, K. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300468 · Cited by 63
Glatt, S. J., & Jönsson, E. G. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30273 · Cited by 63
Bast, T., Zhang, W.-N., Heidbreder, C. A., & Feldon, J. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00589-3 · Cited by 61
Strakowski, S. M., Sax, K. W., Setters, M. J., Stanton, S. P., & Keck, P. E. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00052-8 · Cited by 61
d -Amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice
Huotari, M., Garcia-Horsman, A., Karayiorgou, M., Gogos, J. A., & Männistö, P. T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1627-3 · Cited by 59
GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients
Nadri, C., Dean, B., Scarr, E., & Agam, G. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.020 · Cited by 59
Wan, R., & Corbett, R. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00217-5 · Cited by 58
Kumari, V., Mulligan, O. F., Cotter, P. A., Poon, L. C., Toone, B., Checkley, S. A., & Gray, J. A. (1998) · Behavioural Pharmacology · doi:10.1097/00008877-199811000-00012 · Cited by 58
Multicenter linkage study of schizophrenia loci on chromosome 22q
Mowry, B. J., Holmans, P., Pulver, A. E., Gejman, P. V., Riley, B. P., Williams, N. M., Laurent‐Levinson, C., Schwab, S. G., Wildenauer, D. B., Bauché, S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001481 · Cited by 58
Dopamine receptors labelled by PHNO
Seeman, P. M., Ulpian, C., Larsen, R. D., & Anderson, P. (1993) · Synapse · doi:10.1002/syn.890140403 · Cited by 58
Self-citationA putative animal model of the “prodromal” state of schizophrenia
Tenn, C. C., Fletcher, P. J., & Kapur, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.013 · Cited by 56
Kim, J., & Vezina, P. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00827-4 · Cited by 54
Glutamate Hypothesis of Schizophrenia and Approach for Possible Therapeutic Drugs
Hashimoto, K., Okamura, N., Shimizu, E., & Iyo, M. (2004) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1568015043357011 · Cited by 54
Rc, S., & Jm, D. (1975) · PubMed · Cited by 54
Lähdesmäki, J., Sallinen, J., MacDonald, E., & Scheinin, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300428 · Cited by 53
Dopamine receptor ‘supersensitivity’ occurring without receptor up-regulation
Mileson, B. E., Lewis, M. H., & Mailman, R. B. (1991) · Brain Research · doi:10.1016/0006-8993(91)90742-e · Cited by 53
Phillips, M., Wáng, C., & Johnson, K. M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38833-0 · Cited by 51
Comparison of Haloperidol and Chlorpromazine in the Treatment of Phencyclidine Psychosis
Giannini, A. J., EIGHAN, M. S., Loiselle, R. H., & Giannini, M. C. (1984) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1984.tb01831.x · Cited by 51
Duncan, E., Szilagyi, S., Schwartz, M. P., Kunzova, A., Negi, S., Efferen, T. R., Peselow, E. D., Chakravorty, S., Stephanides, M., Harmon, J. W., et al. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00161-6 · Cited by 50
Carta, A. R., Gerfen, C. R., & Steiner, H. (2000) · Neuroreport · doi:10.1097/00001756-200008030-00012 · Cited by 50
Papiol, S., Molina, V., Desco, M., Rosa, A., Reig, S., Gispert, J. D., Sanz, J., Palomo, T., & Fañanás, L. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.035 · Cited by 50
Risperidone Pretreatment Prevents Elevated Locomotor Activity Following Neonatal Hippocampal Lesions
Richtand, N. M., Taylor, B., Welge, J. A., Ahlbrand, R., Ostrander, M. M., Burr, J., Hayes, S., Coolen, L. M., Pritchard, L. M., Logue, A., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300791 · Cited by 45
Thomsen, W. J., Jacquez, J. A., & Neubig, R. R. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10131-4 · Cited by 45
Graham, S. J., Langley, R. W., Verduzco, A. M. B., Bradshaw, C. M., & Szabadi, E. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600101 · Cited by 43
Karper, P. E., Rosa, H. D. L., Newman, E. R., Krall, C. M., Nazarian, A., McDougall, S. A., & Crawford, C. A. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0936-7 · Cited by 43
Doudet, D. J., Holden, J. E., Jivan, S., McGeer, E. G., & Wyatt, R. J. (2000) · Synapse · doi:10.1002/1098-2396(200011)38:2<105::aid-syn1>3.0.co;2-s · Cited by 43
Boksa, P., Zhang, Y., & Bestawros, A. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7896 · Cited by 42
Self-citationCorripio, I., Pérez, V., Catafau, A. M., Mena, E., Carrió, I., & Álvarez, E. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.07.038 · Cited by 42
Itzhak, Y., & Martin, J. L. (2000) · Psychopharmacology · doi:10.1007/s002130000394 · Cited by 42
Bhardwaj, S. K., Beaudry, G., Quirion, R., Lévesque, D., & Srivastava, L. K. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.016 · Cited by 41
Self-citationThe Concept of Supersensitivity Psychosis
Kirkpatrick, B. W., Alphs, L. D., & Buchanan, R. W. (1992) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199204000-00009 · Cited by 41
Regulators of G protein signaling (RGS proteins): Novel central nervous system drug targets
Neubig, R. R. (2002) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2002.21064.x · Cited by 41
Kruzich, P. J., Suchland, K. L., & Grandy, D. K. (2004) · Synapse · doi:10.1002/syn.20043 · Cited by 39
Schizophrenia genetics: dysbindin under the microscope
Benson, M. A., Sillitoe, R. V., & Blake, D. J. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.004 · Cited by 38
Richtand, N. M., Logue, A. D., Welge, J. A., Perdiue, J., Tubbs, L. J., Spitzer, R. H., Sethuraman, G., & Geracioti, T. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02247-2 · Cited by 38
Giannini, A. J., Nageotte, C., Loiselle, R. H., Malone, D. A., & Price, W. A. (1984) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563658408992586 · Cited by 36
MacKenzie, R. G., & Zigmond, M. J. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05388.x · Cited by 35
Dewey, K. J., & Fibiger, H. C. (1983) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00508341 · Cited by 35
Janowsky, D. S. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770140079009 · Cited by 34
Childhood-onset schizophrenia: smooth pursuit eye-tracking dysfunction in family members
Sporn, A. L., GREENSTEIN, D. K., Gogtay, N., Sailer, F., Hommer, D. W., Rawlings, R. R., Nicolson, R., Egan, M. F., Lenane, M., Gochman, P., et al. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.07.020 · Cited by 32
Perreault, M. L., Graham, D., Bisnaire, L., Simms, J., Hayton, S. J., & Szechtman, H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300938 · Cited by 32
Self-citationThe effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating
Feifel, D., & Priebe, K. (1999) · Psychopharmacology · doi:10.1007/s002130051103 · Cited by 32
Cardiac Muscarinic Receptors. Relationship between the G Protein and Multiple States of Affinity
Green, M. A., Chidiac, P., & Wells, J. W. (1997) · Biochemistry · doi:10.1021/bi961940s · Cited by 31
Jenner, P., Hall, M. D., Murugaiah, K., et al. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90178-2 · Cited by 30
Graham, S. J., Scaife, J. C., Verduzco, A. M. B., Langley, R. W., Bradshaw, C. M., & Szabadi, E. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104042615 · Cited by 29
α2A-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice
Juhila, J., Honkanen, A., Sallinen, J., Haapalinna, A., Korpi, E. R., & Scheinin, M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.05.022 · Cited by 28
Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain
Uehara, T., Tanii, Y., Sumiyoshi, T., & Kurachi, M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01985-5 · Cited by 28
Self-citationLillrank, S. M., Lipska, B. K., Weinberger, D. R., Fredholm, B. B., Fuxé, K., & Ferré, S. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00008-x · Cited by 26
Lomanowska, A. M., Gormley, S., & Szechtman, H. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.12.018 · Cited by 26
Self-citationDopamine agonist action of phencyclidine
Seeman, P. M., & Lasaga, M. (2005) · Synapse · doi:10.1002/syn.20210 · Cited by 26
Self-citationQuantification of dopaminergic supersensitization using apomorphine-induced behavior in the mouse
Randall, P. K. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90081-5 · Cited by 25
Friberg, I. K., Young, A. B., & Standaert, D. G. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00346-x · Cited by 24
Amphetamine-Induced Locomotor Stereotypy in Rats Is Reduced by a D but not a D Antagonist
Fritts, M. E., Mueller, K., & Morris, L. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00308-0 · Cited by 24
D2-like dopamine receptors are not detectable on human peripheral blood lymphocytes
Vile, J. M., & Strange, P. G. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00498-x · Cited by 24
Mechanisms of Agonist Action at D2 Dopamine Receptors
Roberts, D. J., Lin, H., & Strange, P. G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004077 · Cited by 24
Behavioral characterization of dopamine D-sub-5 receptor null mutant mice.
Holmes, A., Hollon, T. R., Gleason, T., Liu, Z., Dreiling, J. L., Sibley, D. R., & Crawley, J. N. (2001) · Behavioral Neuroscience · doi:10.1037//0735-7044.115.5.1129 · Cited by 24
Russig, H., Spooren, W. P. J. M., Durkin, S., Feldon, J., & Yee, B. K. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1810-1 · Cited by 21
Sumiyoshi, T., Tsunoda, M., Uehara, T., Tanaka, K., Itoh, H., Sumiyoshi, C., & Kurachi, M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.04.027 · Cited by 20
Self-citationDorsal hippocampal lesion does not affect dopaminergic indices in the basal ganglia
Lipska, B. K., Jaskiw, G. E., Karoum, F., Phillips, I., Kleinman, J. E., & Weinberger, D. R. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90342-y · Cited by 20
Colussi‐Mas, J., Panayi, F., Scarna, H., Renaud, B., Bérod, A., & Lambás‐Señas, L. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005298 · Cited by 20
Seeman, P. M., Tallerico, T., & Ko, F. (2004) · Synapse · doi:10.1002/syn.20005 · Cited by 19
Self-citationSumiyoshi, T., Seeman, P. M., Uehara, T., Itoh, H., Tsunoda, M., & Kurachi, M. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.07.001 · Cited by 18
Self-citationLoss of cortical acetylcholine enhances amphetamine-induced locomotor activity
Mattsson, A., Pernold, K., Ögren, S. O., & Olson, L. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.038 · Cited by 18
No association of GSK3β gene (GSK3B) with Japanese schizophrenia
Ikeda, M., Iwata, N., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., & Ozaki, N. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30155 · Cited by 18
Carrasco, G. A., Damjanoska, K. J., D’Souza, D. N., Zhang, Y., García, F., Battaglia, G., Muma, N. A., & de Kar, L. D. V. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069807 · Cited by 17
Toxic Psychoses as Pharmacological Models of Schizophrenia
Potvin, S., Stip, É., & Roy, J. (2005) · Current Psychiatry Reviews · doi:10.2174/1573400052953583 · Cited by 14
Estrogen modulates RGS9 expression in the nucleus accumbens
Sharifi, J., Brady, D. L., & Koenig, J. I. (2004) · Neuroreport · doi:10.1097/00001756-200410250-00026 · Cited by 13
Blumer, K. (2003) · Nature · doi:10.1038/427020a · Cited by 13
Juárez, I., de la Cruz, F., Zamudio, S., & Flores, G. (2005) · Synapse · doi:10.1002/syn.20203 · Cited by 11
Meller, E., & Bohmaker, K. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00119-0 · Cited by 11
Comment on "Diverse Psychotomimetics Act Through a Common Signaling Pathway"
Seeman, P. M. (2004) · Science · doi:10.1126/science.1096072 · Cited by 6
Self-citationSoyka, M., Bondy, B., Peuker, B., & Ackenheil, M. (1994) · Journal of Studies on Alcohol · doi:10.15288/jsa.1994.55.503 · Cited by 4
Cited by
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Histamine in the Nervous System
Haas, H. L., Sergeeva, O. A., & Selbach, O. (2008) · Physiological Reviews · doi:10.1152/physrev.00043.2007 · Cited by 1,228
Fone, K. C. F., & Porkess, M. V. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.003 · Cited by 864
Animal models of schizophrenia
Jones, C., Watson, D., & Fone, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01386.x · Cited by 771
Glutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
Metadata
- Authors
- Seeman, P., Schwarz, J., Chen, J.-F., Szechtman, H., Perreault, M., McKnight, G. S., Roder, J. C., Quirion, R., Boksa, P., Srivastava, L. K., Yanai, K., Weinshenker, D., & Sumiyoshi, T.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2006
- Volume
- 60
- Issue
- 4
- Pages
- 319-346
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W1992991774
- Cited by
- 330
- References
- 323
- FWCI
- 13.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.